Phobic Disorders

25 registered clinical trials studyying Phobic Disorders — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Reward Processing and Exposure Therapy for Social Anxiety Disorder NCT06776991	University of California, Los Angeles	N/A
Enrolling By Invitation	Validation of Turkish Versions Child- and Parent-Rated Scales of Food Allergy Anxiety NCT07019389	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization	—
Unknown	Neurophysiological Correlates of Exposition Therapy in Spider Phobia NCT03653923	University Hospital Tuebingen	N/A
Unknown	Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in NCT03188575	Silver Cloud Health	N/A
Completed	The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants NCT03012035	University Hospital, Basel, Switzerland	N/A
Completed	Smartphone-Based Exposure Treatment for Dental Anxiety NCT03461016	West Virginia University	N/A
Unknown	Threat-Avoidance Learning in Anxiety Patients NCT02336802	KU Leuven	—
Completed	A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder NCT02432703	Janssen Research & Development, LLC	Phase 2
Completed	Validity of a Self-administered Questionnaire to Screen Phobia of Falling in the Elderly NCT02387047	Assistance Publique - Hôpitaux de Paris	—
Completed	Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE) NCT02310152	Yale University	N/A
Terminated	Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias NCT01623583	Davita Clinical Research	Phase 4
Unknown	Virtual Reality and Concept of Control in the Treatment of Acrophobia NCT02020824	Qualissima	N/A
Completed	ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder NCT01963806	Stockholm University	N/A
Completed	Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants NCT02007694	VU University of Amsterdam	Phase 2 / Phase 3
Completed	In Vivo Versus Augmented Reality Exposure for Small Animal Phobia NCT01361074	Universitat Jaume I	N/A
Completed	D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia NCT01102803	Southern Methodist University	Phase 3
Terminated	Glucocorticoid Treatment for Social Phobia NCT01574014	Insel Gruppe AG, University Hospital Bern	Phase 2
Completed	Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants NCT00734422	VU University of Amsterdam	Phase 2 / Phase 3
Completed	Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia NCT00128401	National Institute of Mental Health (NIMH)	Phase 2
Completed	RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo NCT00184106	Norwegian University of Science and Technology	Phase 4
Completed	A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions NCT00104195	NYU Langone Health	—
Completed	Study of Escitalopram in the Treatment of Specific Phobia NCT00121069	Connor, Kathryn M., M.D.	Phase 2 / Phase 3
Completed	St. John's Wort Versus Placebo in Social Phobia NCT00035412	National Center for Complementary and Integrative Health (NCCIH)	Phase 2
Completed	Treatment for Specific Phobias in Children NCT00051220	Virginia Polytechnic Institute and State University	Phase 1 / Phase 2
Completed	Treatment of Social Phobia NCT00000370	Boston University Charles River Campus	N/A